A Phase 1 Study of CD19-targeted NEX-T CAR T Cells in Participants with RMS, PMS, or MG(Breakfree-2)

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-507820-22-00

Acronym

CA061-1006

Enrollment

Registered

2024-05-02

Start date

2024-05-22

Completion date

Unknown

Last updated

2025-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myasthenia gravis (MG), Progressive Multiple Sclerosis (PMS), Relapsing Multiple Sclerosis (RMS)

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Belgium, France, Germany, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026